Log in to save to my catalogue

Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma

Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6035749

Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma

About this item

Full title

Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma

Publisher

United States: The American Association for the Advancement of Science

Journal title

Science (American Association for the Advancement of Science), 2018-02, Vol.359 (6377), p.801-806

Language

English

Formats

Publication information

Publisher

United States: The American Association for the Advancement of Science

More information

Scope and Contents

Contents

Immune checkpoint inhibitors induce durable tumor regressions in some, but not all, cancer patients. Understanding the mechanisms that determine tumor sensitivity to these drugs could potentially expand the number of patients who benefit (see the Perspective by Ghorani and Quezada). Pan
et al.
discovered that tumor cells in which a specific S...

Alternative Titles

Full title

Genomic correlates of response to immune checkpoint therapies in clear cell renal cell carcinoma

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6035749

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_6035749

Other Identifiers

ISSN

0036-8075

E-ISSN

1095-9203

DOI

10.1126/science.aan5951

How to access this item